100 related articles for article (PubMed ID: 17317257)
1. HSD17B10 replaces HADH2 as the approved designation for the gene mutated in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency.
Korman SH; Yang SY
Mol Genet Metab; 2007 May; 91(1):115. PubMed ID: 17317257
[No Abstract] [Full Text] [Related]
2. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency is caused by mutations in the HADH2 gene.
Ofman R; Ruiter JP; Feenstra M; Duran M; Poll-The BT; Zschocke J; Ensenauer R; Lehnert W; Sass JO; Sperl W; Wanders RJ
Am J Hum Genet; 2003 May; 72(5):1300-7. PubMed ID: 12696021
[TBL] [Abstract][Full Text] [Related]
3. 3-hydroxyacyl-CoA dehydrogenase (HAD) deficiency replaces short-chain hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency as well as medium- and short-chain hydroxyacyl-CoA dehydrogenase (M/SCHAD) deficiency as the consensus name of this fatty acid oxidation disorder.
He XY; Yang SY
Mol Genet Metab; 2007 Jun; 91(2):205-6. PubMed ID: 17434778
[No Abstract] [Full Text] [Related]
4. Neuroimage findings in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency.
Cazorla MR; Verdú A; Pérez-Cerdá C; Ribes A
Pediatr Neurol; 2007 Apr; 36(4):264-7. PubMed ID: 17437913
[TBL] [Abstract][Full Text] [Related]
5. Comments on 'Significance of developmental expression of amphioxus Branchiostoma belcheri and zebrafish Danio rerio Hsd17b10 in biological and medical research'.
He X; Yang S
J Fish Biol; 2009 May; 74(8):1689-92. PubMed ID: 20735667
[TBL] [Abstract][Full Text] [Related]
6. Spastic diplegia and periventricular white matter abnormalities in 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency, a defect of isoleucine metabolism: differential diagnosis with hypoxic-ischemic brain diseases.
Poll-The BT; Wanders RJ; Ruiter JP; Ofman R; Majoie CB; Barth PG; Duran M
Mol Genet Metab; 2004 Apr; 81(4):295-9. PubMed ID: 15059617
[TBL] [Abstract][Full Text] [Related]
7. A 5-methylcytosine hotspot responsible for the prevalent HSD17B10 mutation.
Yang SY; Dobkin C; He XY; Philipp M; Brown WT
Gene; 2013 Feb; 515(2):380-4. PubMed ID: 23266819
[TBL] [Abstract][Full Text] [Related]
8. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency: impaired catabolism of isoleucine presenting as neurodegenerative disease.
Sass JO; Forstner R; Sperl W
Brain Dev; 2004 Jan; 26(1):12-4. PubMed ID: 14729408
[TBL] [Abstract][Full Text] [Related]
9. 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency in a 23-year-old man.
Olpin SE; Pollitt RJ; McMenamin J; Manning NJ; Besley G; Ruiter JP; Wanders RJ
J Inherit Metab Dis; 2002 Oct; 25(6):477-82. PubMed ID: 12555940
[TBL] [Abstract][Full Text] [Related]
10. HSD10 mitochondrial disease: p.Leu122Val variant, mild clinical phenotype, and founder effect in French-Canadian patients from Quebec.
Waters PJ; Lace B; Buhas D; Gravel S; Cyr D; Boucher RM; Bernard G; Lévesque S; Maranda B
Mol Genet Genomic Med; 2019 Dec; 7(12):e1000. PubMed ID: 31654490
[TBL] [Abstract][Full Text] [Related]
11. [Mutation analysis of a family with 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency].
Shu JB; Zhang YQ; Jiang SZ; Zhang CH; Meng YT; Wang H; Song L
Zhonghua Er Ke Za Zhi; 2013 Oct; 51(10):783-6. PubMed ID: 24406234
[TBL] [Abstract][Full Text] [Related]
12. Expression of Clostridium acetobutylicum butanol synthetic genes in Escherichia coli.
Inui M; Suda M; Kimura S; Yasuda K; Suzuki H; Toda H; Yamamoto S; Okino S; Suzuki N; Yukawa H
Appl Microbiol Biotechnol; 2008 Jan; 77(6):1305-16. PubMed ID: 18060402
[TBL] [Abstract][Full Text] [Related]
13. The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis, and abnormal behavior.
Lenski C; Kooy RF; Reyniers E; Loessner D; Wanders RJ; Winnepenninckx B; Hellebrand H; Engert S; Schwartz CE; Meindl A; Ramser J
Am J Hum Genet; 2007 Feb; 80(2):372-7. PubMed ID: 17236142
[TBL] [Abstract][Full Text] [Related]
14. [Short-chain 3-hydroxyacyl-CoA dehydrogenase (SCHAD) deficiency].
Takusa Y; Yamaguchi S
Ryoikibetsu Shokogun Shirizu; 2001; (36):74-6. PubMed ID: 11596455
[No Abstract] [Full Text] [Related]
15. Study of patients and carriers with 2-methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: difficulties in the diagnosis.
García-Villoria J; Navarro-Sastre A; Fons C; Pérez-Cerdá C; Baldellou A; Fuentes-Castelló MA; González I; Hernández-Gonzalez A; Fernández C; Campistol J; Delpiccolo C; Cortés N; Messeguer A; Briones P; Ribes A
Clin Biochem; 2009 Jan; 42(1-2):27-33. PubMed ID: 18996107
[TBL] [Abstract][Full Text] [Related]
16. HSD17B10: a gene involved in cognitive function through metabolism of isoleucine and neuroactive steroids.
Yang SY; He XY; Miller D
Mol Genet Metab; 2007; 92(1-2):36-42. PubMed ID: 17618155
[TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxy-2-methylbutyryl-CoA dehydrogenase deficiency.
Sutton VR; O'Brien WE; Clark GD; Kim J; Wanders RJ
J Inherit Metab Dis; 2003; 26(1):69-71. PubMed ID: 12872843
[TBL] [Abstract][Full Text] [Related]
18. 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency: an X-linked inborn error of isoleucine metabolism that may mimic a mitochondrial disease.
Perez-Cerda C; García-Villoria J; Ofman R; Sala PR; Merinero B; Ramos J; García-Silva MT; Beseler B; Dalmau J; Wanders RJ; Ugarte M; Ribes A
Pediatr Res; 2005 Sep; 58(3):488-91. PubMed ID: 16148061
[TBL] [Abstract][Full Text] [Related]
19. The first case in Asia of 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency (HSD10 disease) with atypical presentation.
Fukao T; Akiba K; Goto M; Kuwayama N; Morita M; Hori T; Aoyama Y; Venkatesan R; Wierenga R; Moriyama Y; Hashimoto T; Usuda N; Murayama K; Ohtake A; Hasegawa Y; Shigematsu Y; Hasegawa Y
J Hum Genet; 2014 Nov; 59(11):609-14. PubMed ID: 25231369
[TBL] [Abstract][Full Text] [Related]
20. Hyperinsulinism of infancy associated with a novel splice site mutation in the SCHAD gene.
Hussain K; Clayton PT; Krywawych S; Chatziandreou I; Mills P; Ginbey DW; Geboers AJ; Berger R; van den Berg IE; Eaton S
J Pediatr; 2005 May; 146(5):706-8. PubMed ID: 15870679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
